|
in vivo model
|
in_vivo_model |
|
|
CA1 field of hippocampus
|
CA1_field_of_hippocampus |
|
|
DISC1 mutant mouse model
|
DISC1_mutant_mouse_model |
|
|
TAP1 knockout mouse model
|
TAP1_knockout_mouse_model |
|
|
gene-environment interaction model
|
gene-environment_interaction_model |
|
|
orbitofrontal cortex
|
orbitofrontal_cortex |
|
|
urinary toxicology screening
|
urinary_toxicology_screening |
|
|
increased protein kinase A activity
|
increased_protein_kinase_A_activity |
|
|
tobacco use
|
tobacco_use |
|
|
behavior
|
behavior |
|
|
cocaine abuse
|
cocaine_abuse |
|
|
T-helper 17 cell
|
T-helper_17_cell |
|
|
fluorescent in situ hybridization
|
fluorescent_in_situ_hybridization |
|
|
gout
|
gout |
|
|
chronic schizophrenia
|
chronic_schizophrenia |
|
|
shared psychotic disorder
|
shared_psychotic_disorder |
|
|
World Health Organization disability assessment schedule 2.0 36-item version interviewer-administered questionnaire
|
World_Health_Organization_disability_assessment_schedule_2.0_36-item_version_interviewer-administered_questionnaire |
|
|
abnormality of the eye
|
abnormality_of_the_eye |
|
|
antidepressant type abuse
|
antidepressant_type_abuse |
|
|
pre-eclampsia
|
pre-eclampsia |
|
